Verition Fund Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
61,185
-293,674
-83% -$6.91M 0.01% 1221
2026
Q1
$5.31M Buy
354,859
+90,712
+34% +$1.55M 0.03% 552
2025
Q4
$3.85M Buy
264,147
+228,946
+650% +$3.99M 0.02% 1073
2025
Q3
$632K Sell
35,201
-548,737
-94% -$8.05M ﹤0.01% 2880
2025
Q2
$9.97M Buy
+583,938
New +$5.84M 0.04% 530
2025
Q1
Sell
-194,661
Closed -$2.73M 3378
2024
Q4
$2.73M Buy
194,661
+102,104
+110% +$1.51M 0.01% 1345
2024
Q3
$1.1M Buy
92,557
+12,925
+16% +$134K 0.01% 1825
2024
Q2
$741K Buy
79,632
+48,441
+155% +$247K ﹤0.01% 1842
2024
Q1
$110K Buy
+31,191
New +$108K ﹤0.01% 2570

Other funds holding CORZ

Verition Fund Management's CORZ Position: Q2 2026 in Review

Verition Fund Management reduced its Core Scientific (CORZ) stake by 83% in Q2 2026, selling an estimated $6.91M and leaving 61,185 shares worth $1.57M. The position accounts for 0.01% of the portfolio, ranked #1221.

Verition Fund Management first reported a position in CORZ in Q1 2024 and has held it in 9 quarters since. The position peaked at $9.97M in Q2 2025. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Verition Fund Management held 61,185 shares of Core Scientific worth $1.57M as of Q2 2026.
  • Verition Fund Management sold 293,674 Core Scientific shares in Q2 2026, an estimated $6.91M.
  • Core Scientific made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #1221 holding.
  • Verition Fund Management first reported a position in Core Scientific in Q1 2024 and has held it in 9 quarters since.
  • Verition Fund Management's Core Scientific position peaked at $9.97M in Q2 2025.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.